Report on the first quarter of 2013 for ROCKWOOL International...Release no. 5 2013 Report on the first quarter of 2013 To NASDAQ OMX Nordic Exchange Copenhagen A/S This is a translation of the Danish version. Only the Danish version is legally binding. ROCKWOOL INTERNATIONAL A/S Hovedgaden 584, Entrance C ... NASDAQ OMX, 1 day ago
EpiCept Corporation (EPCT) Reports First Quarter 2013 Operating and Financial Results
- BioSpace, 2 days ago
|
217 images for nasdaq omx | ||||
NKT Holding Interim Report Q1 2013NASDAQ OMX Copenhagen Nikolaj Plads 6 DK-1007 Copenhagen K 22 May 2013 Release No. 11 NKT: Positve growth - and earnings as expected Q1 2013 showed satisfactory organic growth of 2%. NKT's revenue increased with 53 mDKK to 2,859 mDKK in standard ... NASDAQ OMX, 1 day ago
NKT HOLDING A/S: NKT Holding Interim Report Q1 2013
4 Traders, 1 day ago
|
RIG: NASDAQ OMX Riga investor calendar, week 21/2013NASDAQ OMX, 3 days ago VLN: NASDAQ OMX Vilnius investor calendar, week 21/2013 NASDAQ OMX, 3 days ago |
POWERSHARES GLOBAL AGRI NASDAQ OMX FUND - Net Asset Value(s)National Storage Mechanism Appointed by the FCA to act as the official mechanism for the storage of regulated information in the UK PR Newswire London, May 21 Funds Date Ticker ISIN code Shares in Currency Net Asset NAV/per Symbol Issue Value share ... Morningstar UK, 2 days ago
|
POWERSHARES NASDAQ OMX GLOBAL WATER FUND - Net Asset Value(s)National Storage Mechanism Appointed by the FCA to act as the official mechanism for the storage of regulated information in the UK PR Newswire London, May 17 Funds Date Ticker ISIN code Shares in Currency Net Asset NAV/per Symbol Issue Value share ... Morningstar UK, 3 days ago
|
European Medicines Agency (EMA) Accepts Veloxis Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant PatientsCompany Announcement no. 13/2013 To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, May 21, 2013 Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that the European Medicines Agency (EMA) accepted for review the company's Marketing ... NASDAQ OMX, 2 days ago
European Medicines Agency Accepts Veloxis Pharmaceuticals A/S' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients
BioSpace, 1 day ago
|
The Nasdaq OMX Group's CEO Hosts Annual Shareholder Meeting (Transcript)The NASDAQ OMX Group, Inc. (NDAQ) Annual Shareholder Meeting May 22, 2013 9:00 AM ET Brje E. Ekholm Let's see if we can get this focused on one meeting. So good morning, everyone. My name is Brje Ekholm, I'm the Chairman of the NASDAQ OMX board and ... Seeking Alpha, 1 day ago
NASDAQ OMX Group's Outperform Rating Reaffirmed at Macquarie (NDAQ)
American Banking News, 1 day ago
BGC Partners Gets HSR Approval For Proposed Sale Of Certain Assets To Nasdaq Omx
RTTNews.com, 3 days ago
BGC Partners (BGCP) announces regulatory approval for the sale of its eSpeed Treasury trading platform to Nasdaq OMX (NDAQ). The deal is a combination of cash and stock that could total up to $1.234B. (PR)
Seeking Alpha, 3 days ago
|
Tribona Real Estate Company to be listed on the NASDAQ OMX Stockholm ExchangeTribona, a pure play logistics and warehouse property company, is today, May 21 2013, listed on the NASDAQ OMX Stockholm Exchange. The shares of the company (ticker symbol TRI) will be traded on the Mid Cap list under the Properties sector. No new ... NASDAQ OMX, 2 days ago
Tribona to be listed on Nasdaq OMX Stockholm Exchange
Property Funds World, 1 day ago
Tribona ASA: Approval of Tribona AB's listing on the Nasdaq OMX Stockholm and the approval and registration of prospectus
Andhra News, 3 weeks ago
|
Self-Regulatory Organizations; NASDAQ OMX PHLX LLC; Notice of Filing of Proposed Rule Change to Its Schedule of Fees and Rebates for Execution of Quotes and Orders on NASDAQ OMX PSXPursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 ("Act") *1 and Rule 19b-4 thereunder, *2 notice is hereby given that, on May 3, 2013, NASDAQ OMX PHLX LLC ("Phlx" or "Exchange") filed with the Securities and Exchange Commission ... TMC Net, 2 days ago
|
Zealand to present at upcoming global healthcare investor conferences in the USZealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) (Zealand), a Danish biotechnology company dedicated to the discovery and development of novel peptide drugs, informs it will present at the following upcoming healthcare investor conferences in the ... NASDAQ OMX, 2 days ago
Zealand Pharma to Present at Upcoming Global Healthcare Investor Conferences in the U.S.
BioSpace, 2 days ago
Zealand Pharma to Present at Upcoming Global Healthcare Investor Conferences in the U.S.
BioSpace, 2 days ago
|